Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Fromm

Showing results (131-140 of 187) with videos related to

Pageof 19
Sort By:
Studies in Health Technology and Informatics|August 28, 2014
The effect object paradigm--a means to support medication safety with clinical decision supportAndrius Patapovas, Barbara Pfistermeister, Aleksey Tarkhov, et al.
Pharmacogenetics and Genomics|June 14, 2008
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1Stefan Oswald, Jörg König, Dieter Lütjohann, et al.
Pharmacological Reviews|December 29, 2019
Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic DiseaseTina Schumann, Jörg König, Christine Henke, et al.
Clinical Pharmacology and Therapeutics|January 13, 2023
N<sup>1</sup> -Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug-Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and ProbenecidFabian Müller, Kathrin Hohl, Sascha Keller, et al.
Cancer Biology & Therapy|February 1, 2011
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissueJuergen Kindla, Tilman T Rau, Rudolf Jung, et al.
British Journal of Clinical Pharmacology|April 23, 2020
Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteersShingen Misaka, Osamu Abe, Tomoyuki Ono, et al.
Molecular Pharmacology|September 27, 2022
Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitorsBastian Haberkorn, Stefan Oswald, Niklas Kehl, et al.
Journal of Clinical Pharmacology|November 26, 2009
Gender is an important determinant of the disposition of the loop diuretic torasemideUlrike Werner, Dierk Werner, Svetlana Heinbüchner, et al.
Clinical Pharmacokinetics|May 19, 2026
Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma ConcentrationsPhyllis Lensker, Andrea Gottschalk, Thomas Zerjatke, et al.
Pharmacogenetics|April 30, 2004
Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1)Monika Hitzl, Elke Schaeffeler, Berthold Hocher, et al.
Pageof 19

Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Studies in Health Technology and Informatics|August 28, 2014
The effect object paradigm--a means to support medication safety with clinical decision supportAndrius Patapovas, Barbara Pfistermeister, Aleksey Tarkhov, et al.
Pharmacogenetics and Genomics|June 14, 2008
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1Stefan Oswald, Jörg König, Dieter Lütjohann, et al.
Pharmacological Reviews|December 29, 2019
Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic DiseaseTina Schumann, Jörg König, Christine Henke, et al.
Clinical Pharmacology and Therapeutics|January 13, 2023
N<sup>1</sup> -Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug-Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and ProbenecidFabian Müller, Kathrin Hohl, Sascha Keller, et al.
Cancer Biology & Therapy|February 1, 2011
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissueJuergen Kindla, Tilman T Rau, Rudolf Jung, et al.
British Journal of Clinical Pharmacology|April 23, 2020
Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteersShingen Misaka, Osamu Abe, Tomoyuki Ono, et al.
Molecular Pharmacology|September 27, 2022
Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitorsBastian Haberkorn, Stefan Oswald, Niklas Kehl, et al.
Journal of Clinical Pharmacology|November 26, 2009
Gender is an important determinant of the disposition of the loop diuretic torasemideUlrike Werner, Dierk Werner, Svetlana Heinbüchner, et al.
Clinical Pharmacokinetics|May 19, 2026
Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma ConcentrationsPhyllis Lensker, Andrea Gottschalk, Thomas Zerjatke, et al.
Pharmacogenetics|April 30, 2004
Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1)Monika Hitzl, Elke Schaeffeler, Berthold Hocher, et al.
Pageof 19